Lymphoma, B-Cell, Marginal Zone
"Lymphoma, B-Cell, Marginal Zone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.
| Descriptor ID |
D018442
|
| MeSH Number(s) |
C04.557.386.480.150.570 C15.604.515.569.480.150.570 C20.683.515.761.480.150.570
|
| Concept/Terms |
Lymphoma, B-Cell, Marginal Zone- Lymphoma, B-Cell, Marginal Zone
- MALT Lymphoma
- Lymphoma, MALT
- Lymphomas, MALT
- MALT Lymphomas
- Lymphoma of Mucosa-Associated Lymphoid Tissue
- Lymphoma of Mucosa Associated Lymphoid Tissue
- Mucosa-Associated Lymphoid Tissue Lymphoma
- Mucosa Associated Lymphoid Tissue Lymphoma
- Lymphoma, Mucosa-Associated Lymphoid Tissue
- Lymphoma, Mucosa Associated Lymphoid Tissue
- Marginal Zone B-Cell Lymphoma
- Marginal Zone B Cell Lymphoma
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, B-Cell, Marginal Zone".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Lymphoma [C04.557.386]
- Lymphoma, Non-Hodgkin [C04.557.386.480]
- Lymphoma, B-Cell [C04.557.386.480.150]
- Lymphoma, B-Cell, Marginal Zone [C04.557.386.480.150.570]
- Hemic and Lymphatic Diseases [C15]
- Lymphatic Diseases [C15.604]
- Lymphoproliferative Disorders [C15.604.515]
- Lymphoma [C15.604.515.569]
- Lymphoma, Non-Hodgkin [C15.604.515.569.480]
- Lymphoma, B-Cell [C15.604.515.569.480.150]
- Lymphoma, B-Cell, Marginal Zone [C15.604.515.569.480.150.570]
- Immune System Diseases [C20]
- Immunoproliferative Disorders [C20.683]
- Lymphoproliferative Disorders [C20.683.515]
- Lymphoma [C20.683.515.761]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Lymphoma, B-Cell [C20.683.515.761.480.150]
- Lymphoma, B-Cell, Marginal Zone [C20.683.515.761.480.150.570]
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, B-Cell, Marginal Zone".
This graph shows the total number of publications written about "Lymphoma, B-Cell, Marginal Zone" by people in this website by year, and whether "Lymphoma, B-Cell, Marginal Zone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 5 | 1 | 6 |
| 1998 | 1 | 1 | 2 |
| 1999 | 5 | 0 | 5 |
| 2000 | 1 | 3 | 4 |
| 2001 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 4 | 0 | 4 |
| 2015 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, B-Cell, Marginal Zone" by people in Profiles.
-
Orbital Richter Transformation With Subsequent Orbital MALT-type Lymphoma in a Patient With Chronic Lymphocytic Leukemia. Ophthalmic Plast Reconstr Surg. 2024 Nov-Dec 01; 40(6):e205-e209.
-
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial. Lancet Haematol. 2024 Jul; 11(7):e521-e529.
-
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5). Blood. 2024 02 08; 143(6):496-506.
-
Primary Canalicular MALT Lymphoma Masquerading as Chronic Canaliculitis. Ophthalmic Plast Reconstr Surg. 2024 Mar-Apr 01; 40(2):e51-e52.
-
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma. Blood Adv. 2023 11 28; 7(22):7141-7150.
-
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study. Cancer. 2024 03 15; 130(6):876-885.
-
False CD10 positivity in MALT lymphoma involving kidney. Blood. 2022 12 22; 140(25):2760.
-
Specific location of ocular adnexal lymphoma and mortality: an international multicentre retrospective study. Br J Ophthalmol. 2023 09; 107(9):1231-1238.
-
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood Adv. 2022 04 12; 6(7):2035-2044.
-
Helicobacter pylori cagA status and gastric mucosa-associated lymphoid tissue lymphoma: a systematic review and meta-analysis. J Health Popul Nutr. 2022 01 03; 41(1):2.